[go: up one dir, main page]

DE60006116D1 - A2a rezeptor agonisten - Google Patents

A2a rezeptor agonisten

Info

Publication number
DE60006116D1
DE60006116D1 DE60006116T DE60006116T DE60006116D1 DE 60006116 D1 DE60006116 D1 DE 60006116D1 DE 60006116 T DE60006116 T DE 60006116T DE 60006116 T DE60006116 T DE 60006116T DE 60006116 D1 DE60006116 D1 DE 60006116D1
Authority
DE
Germany
Prior art keywords
receptor agonists
disclosed
purposes
alkylthienyl
adenosines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006116T
Other languages
English (en)
Other versions
DE60006116T2 (de
Inventor
A Zablocki
O Elzein
P Palle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Palo Alto Inc
Original Assignee
CV Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Therapeutics Inc filed Critical CV Therapeutics Inc
Publication of DE60006116D1 publication Critical patent/DE60006116D1/de
Application granted granted Critical
Publication of DE60006116T2 publication Critical patent/DE60006116T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60006116T 1999-06-22 2000-06-20 A2a rezeptor agonisten Expired - Lifetime DE60006116T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14047899P 1999-06-22 1999-06-22
US140478P 1999-06-22
PCT/US2000/016856 WO2000078776A2 (en) 1999-06-22 2000-06-20 Thiophene a2a receptor agonists

Publications (2)

Publication Number Publication Date
DE60006116D1 true DE60006116D1 (de) 2003-11-27
DE60006116T2 DE60006116T2 (de) 2004-07-08

Family

ID=22491411

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006116T Expired - Lifetime DE60006116T2 (de) 1999-06-22 2000-06-20 A2a rezeptor agonisten

Country Status (19)

Country Link
US (1) US6440948B1 (de)
EP (1) EP1194441B1 (de)
JP (1) JP2003502434A (de)
KR (1) KR100463694B1 (de)
CN (1) CN1166677C (de)
AT (1) ATE252595T1 (de)
AU (1) AU768530B2 (de)
BR (1) BR0011853A (de)
CA (1) CA2373410C (de)
DE (1) DE60006116T2 (de)
ES (1) ES2206259T3 (de)
HK (1) HK1048821B (de)
IL (2) IL147194A0 (de)
MX (1) MXPA01013323A (de)
NO (1) NO20016242L (de)
NZ (1) NZ516336A (de)
TR (1) TR200200617T2 (de)
WO (1) WO2000078776A2 (de)
ZA (1) ZA200200299B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5879299A (en) * 1998-10-16 2000-05-08 Monaghan, Sandra Marina Adenine derivatives
CN1279984C (zh) 2002-02-15 2006-10-18 Cv医药有限公司 用于医用装置的聚合物涂层
TWI346109B (en) * 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
CN103087133B (zh) * 2004-05-26 2016-09-14 伊诺泰克制药公司 嘌呤衍生物作为腺苷a1受体激动剂及其用法
BRPI0515506A (pt) * 2004-09-20 2008-07-29 Inotek Pharmaceuticals Corp derivados de purina e métodos de uso dos mesmos
NZ568392A (en) * 2005-11-30 2011-07-29 Inotek Pharmaceuticals Corp Purine derivatives and methods of use thereof
EP2523669B1 (de) 2010-01-11 2016-12-07 Inotek Pharmaceuticals Corporation Kombination, kit und verfahren zur reduzierung des augeninnendrucks
JP2013523739A (ja) 2010-03-26 2013-06-17 イノテック ファーマシューティカルズ コーポレイション Ｎ６−シクロペンチルアデノシン（ｃｐａ）、ｃｐａ誘導体またはそれらのプロドラッグを用いてヒトにおける眼内圧を低下させる方法
NZ627778A (en) 2012-01-26 2017-01-27 Inotek Pharmaceuticals Corp Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
BR112015021870A2 (pt) 2013-03-15 2017-07-18 Inotek Pharmaceuticals Corp formulações oftálmicas
JP7100854B2 (ja) 2017-01-13 2022-07-14 東菱薬品工業株式会社 好中球活性化調節剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135130B (da) * 1970-12-28 1977-03-07 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf.
JPS4911896A (de) * 1972-05-15 1974-02-01
JPS5518625B2 (de) * 1973-07-26 1980-05-20
US5070877A (en) 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
PL297372A1 (en) * 1991-04-06 1993-09-06 Fisons Plc Atp analogs

Also Published As

Publication number Publication date
ES2206259T3 (es) 2004-05-16
EP1194441B1 (de) 2003-10-22
CN1166677C (zh) 2004-09-15
CA2373410C (en) 2006-08-29
TR200200617T2 (tr) 2002-06-21
BR0011853A (pt) 2002-04-30
KR100463694B1 (ko) 2004-12-29
ATE252595T1 (de) 2003-11-15
CA2373410A1 (en) 2000-12-28
ZA200200299B (en) 2003-08-27
MXPA01013323A (es) 2003-10-15
KR20020028912A (ko) 2002-04-17
NO20016242L (no) 2002-02-21
EP1194441A2 (de) 2002-04-10
WO2000078776A2 (en) 2000-12-28
AU5625100A (en) 2001-01-09
NZ516336A (en) 2004-01-30
HK1048821A1 (en) 2003-04-17
IL147194A0 (en) 2002-08-14
HK1048821B (zh) 2005-02-25
DE60006116T2 (de) 2004-07-08
NO20016242D0 (no) 2001-12-19
JP2003502434A (ja) 2003-01-21
AU768530B2 (en) 2003-12-18
CN1364170A (zh) 2002-08-14
IL147194A (en) 2007-08-19
WO2000078776A3 (en) 2001-06-28
US6440948B1 (en) 2002-08-27

Similar Documents

Publication Publication Date Title
CA2377746A1 (en) N-pyrazole a2a receptor agonists
BR0011854A (pt) Agonistas de receptores de a2a de c-pirazola
NZ522326A (en) Adenosine A2A receptor antagonists
ATE252595T1 (de) A2a rezeptor agonisten
TNSN99191A1 (fr) Derives d'adenine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MY148937A (en) Medicaments with hm74a receptor activity
TR200201001T2 (tr) Pürin türevleri
UA66945C2 (uk) ПОХІДНІ ПУРИНУ З ВЛАСТИВОСТЯМИ АГОНІСТА ЛЮДСЬКОГО А2<sub>А</sub> РЕЦЕПТОРА, СПОСІБ ЇХ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ
CY1108823T1 (el) Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
DK0975595T3 (da) Kokainanaloger
JP2013502424A5 (de)
JPH11509181A (ja) 水溶性アデノシンキナーゼ阻害剤
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
EP1797878A3 (de) Benzothiazolderivate
DE122007000062I1 (de) Beta-L-2'-deoxynukleoside für die Behandlung von Hepatitis-B-Virus
NO20021448L (no) Nye tiazolo-(4,5-D)pyrimidinforbindelser
MXPA03001344A (es) Derivados de piridina 2,4-substituidos.
BR0111438A (pt) Análogos de ácido barbitúrico como agentes terapeuticos
CA2375385A1 (en) Propargyl phenyl ether a2a receptor agonists
FI884375A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
TR200103680T2 (tr) IL-8 reseptör antagonistleri.
ATE389655T1 (de) Pyrimidinderivate
ATE277639T1 (de) Zusammensetzungen von adenosin a1 agonisten und 5ht3 agonisten
MXPA05012369A (es) Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition